Additionally, the 36-month beta value for NVNO is 1.12. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for NVNO is 13.27M and currently, short sellers hold a 6.19% ratio of that float. The average trading volume of NVNO on April 24, 2024 was 130.52K shares.
NVNO) stock’s latest price update
enVVeno Medical Corporation (NASDAQ: NVNO)’s stock price has soared by 12.02 in relation to previous closing price of 4.91. Nevertheless, the company has seen a gain of 15.55% in its stock price over the last five trading days.
NVNO’s Market Performance
enVVeno Medical Corporation (NVNO) has experienced a 15.55% rise in stock performance for the past week, with a -2.65% drop in the past month, and a 31.26% rise in the past quarter. The volatility ratio for the week is 7.61%, and the volatility levels for the past 30 days are at 5.55% for NVNO. The simple moving average for the past 20 days is 8.18% for NVNO’s stock, with a 13.45% simple moving average for the past 200 days.
NVNO Trading at -0.15% from the 50-Day Moving Average
After a stumble in the market that brought NVNO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -21.09% of loss for the given period.
Volatility was left at 5.55%, however, over the last 30 days, the volatility rate increased by 7.61%, as shares surge +0.18% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +7.42% upper at present.
During the last 5 trading sessions, NVNO rose by +15.55%, which changed the moving average for the period of 200-days by +39.59% in comparison to the 20-day moving average, which settled at $5.08. In addition, enVVeno Medical Corporation saw 7.00% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at NVNO starting from Alavi Hamed, who sale 8,334 shares at the price of $6.22 back on Mar 13 ’24. After this action, Alavi Hamed now owns 0 shares of enVVeno Medical Corporation, valued at $51,837 using the latest closing price.
Stock Fundamentals for NVNO
Current profitability levels for the company are sitting at:
- -30.63 for the present operating margin
- 0.34 for the gross margin
The net margin for enVVeno Medical Corporation stands at -27.61. The total capital return value is set at -0.53. Equity return is now at value -55.38, with -52.09 for asset returns.
Based on enVVeno Medical Corporation (NVNO), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -13.45.
Currently, EBITDA for the company is -24.69 million with net debt to EBITDA at 0.09. When we switch over and look at the enterprise to sales, we see a ratio of 86.2. The liquidity ratio also appears to be rather interesting for investors as it stands at 34.23.
Conclusion
In conclusion, enVVeno Medical Corporation (NVNO) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
